CDRxAb: Antibody Small-Molecule Conjugates with Computationally Designed Target-Binding Synergy
<p>Antibody-drug conjugates (ADCs), or chimeric modalities in general, combine the advantages and offset the flaws of their constituent parts to achieve a broader target space than traditional approaches of pharmaceutical development. My project combines the concept of ADCs with the full atomi...